Low dose botulinum toxin in spasmodic torticollis

Area of Science:

• Neurology
• Pharmacology

Background:

• Spasmodic torticollis is a debilitating condition affecting neck muscle movement.
• Botulinum toxin injections are a common treatment, but optimal dosage remains debated.
• Current UK recommendations suggest 20-25 ng, with potential for dose-related side effects.

Purpose of the Study:

• To evaluate the efficacy and safety of lower botulinum toxin doses for spasmodic torticollis.
• To determine if reduced dosages can maintain therapeutic benefits while minimizing adverse events.

Main Methods:

• A cohort of 12 patients with spasmodic torticollis (mean duration 4 years) received low-dose botulinum toxin injections (average 13 ng).
• Patient outcomes were assessed based on improvements in pain scores and degree of head movement.
• Treatment efficacy and side effects were monitored over a 3-month period.

Main Results:

• 91% of patients (11 out of 12) experienced significant improvement in pain and head movement.
• Therapeutic benefits were observed within one week and persisted for 3 months post-treatment.
• Reported side effects were minimal and transient, suggesting good tolerability.

Conclusions:

• Lower doses of botulinum toxin (average 13 ng) appear to be as efficacious as higher doses for treating spasmodic torticollis.
• Utilizing reduced dosages may lead to a favorable reduction in treatment-related side effects.
• Further research into low-dose botulinum toxin therapy for spasmodic torticollis is warranted.